Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
In pancreatic cancer, the epigenomic landscape can strongly impact the disease phenotype. Here, the authors discuss recent advances in our understanding of pancreatic cancer epigenomics, and how this knowledge can integrate with precision medicine approaches in this lethal disease.
Main Authors: | Gwen Lomberk, Nelson Dusetti, Juan Iovanna, Raul Urrutia |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-11812-7 |
Similar Items
-
Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome
by: Natalia Anahi Juiz, et al.
Published: (2019-04-01) -
Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance
by: Abdessamad El Kaoutari, et al.
Published: (2021-04-01) -
Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression Networks
by: Guillermo Urrutia, et al.
Published: (2021-06-01) -
Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
by: Gwen Lomberk, et al.
Published: (2018-05-01) -
Epigenomics of Pancreatic Cancer: A Critical Role for Epigenome-Wide Studies
by: Rahul R. Singh, et al.
Published: (2019-01-01)